FDA advisers vote against first MDMA therapy to treat PTSD
Jun 4, 2024 · A federal advisory committee on Tuesday voted overwhelmingly against of the use of MDMA, commonly known as ecstasy, as a treatment for post-traumatic stress disorder.
F.D.A. Declines to Approve MDMA Therapy, Seeking More Study
Aug 9, 2024 · The Food and Drug Administration on Friday declined to approve MDMA-assisted therapy for the treatment of post-traumatic stress disorder, dealing a serious blow to the nascent field of...
FDA declines to approve novel MDMA therapy to treat PTSD, with ... - CNN
Aug 9, 2024 · The US Food and Drug Administration has declined to approve an application for the use of MDMA, commonly known as ecstasy, as a treatment for post-traumatic stress disorder, according to a news...
FDA rejects MDMA, disappointing drugmaker Lykos and psychedelics ... - NPR
Aug 9, 2024 · On Friday, drugmaker Lykos Therapeutics received word from the Food and Drug Administration that the agency has decided not to approve MDMA-assisted therapy for PTSD at this time. Instead,...
FDA rejection of MDMA-assisted therapy rattles advocates but ... - CNN
Aug 13, 2024 · CNN — The path toward federal approval for medical treatments involving psychedelics may be longer and less straightforward after the US Food and Drug Administration denied the first application...
FDA panel rejects first MDMA treatment amid deep concerns ... - NBC News
Jun 4, 2024 · A Food and Drug Administration advisory panel on Tuesday declined to recommend the approval of MDMA, commonly known as ecstasy or molly, as a treatment for post-traumatic stress disorder, a...
MDMA Therapy Inches Closer to Approval - The New York Times
Sep 14, 2023 · MDMA-assisted therapy seems to be effective in reducing symptoms of post-traumatic stress disorder, according to a study published on Thursday. The research is the final trial conducted by MAPS...
Psychedelic drug MDMA moves closer to US approval following
Sep 14, 2023 · The psychedelic drug MDMA, also known as ecstasy or molly, has passed another key hurdle on its way to regulatory approval as a treatment for mental illness. A second large clinical trial has...
FDA Panel Rejects Use of MDMA for Treatment of PTSD - The New York Times
June 4, 2024. An independent advisory panel of the Food and Drug Administration rejected the use of MDMA-assisted therapy for post-traumatic stress disorder on Tuesday, highlighting the...
Will MDMA's FDA setback derail psychedelic drug research? : Shots ... - NPR
Jun 13, 2024 · The psychedelic drug MDMA is near the end of a decades-long effort to enter mainstream medicine but instead of celebrating, supporters now find themselves wondering if the treatment will actually...
- Some results have been removed